Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MOUNT LAUREL, N.J., Jan. 16, 2026 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) today announced that it will release financial results for its fiscal first quarter ended December...
-
Jakarta, Jan. 16, 2026 (GLOBE NEWSWIRE) -- NusaTrip Incorporated (Nasdaq: NUTR) (“NusaTrip,” “NUTR,” or the “Company”), a travel ecosystem with geographical specialization in Southeast Asia and...
-
HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce...
-
LIMASSOL, Cyprus, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Toro Corp. (NASDAQ: TORO) (“Toro”, or the “Company”), a global energy transportation provider today announces the results of shareholder elections...
-
WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...
-
VALENCIA, Spain, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Turbo Energy S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global provider of AI-optimized solar energy storage technologies and...
-
DENVER, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Since its founding in 2004, First Western Trust has remained deeply committed to building strong, vibrant communities through philanthropy, economic...
-
VANCOUVER, British Columbia and BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery,...
-
Arteris announces new employment inducement grants
-
CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...